These results are the first to demonstrate altered DREAM expression in SSc and suggest that enhanced DREAM in SSc fibroblasts might be directly responsible for the reduced levels of A20 in a cell-autonomous fashion34. This evidence concerns the gene KCNIP3 and systemic sclerosis.